UK markets close in 3 hours 56 minutes

Hikma Pharmaceuticals PLC (HIK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
2,640.00+38.00 (+1.46%)
As of 12:19PM GMT. Market open.
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
2,138,000
2,207,000
2,070,000
1,936,000
1,950,000
Cost of revenue
1,030,000
1,059,000
1,020,000
969,000
964,000
Gross profit
1,108,000
1,148,000
1,050,000
967,000
986,000
Operating expenses
Research development
156,000
150,000
147,000
121,000
150,000
Selling general and administrative
482,000
494,000
470,000
475,000
392,000
Total operating expenses
666,000
698,000
672,000
644,000
623,000
Operating income or loss
442,000
450,000
378,000
323,000
363,000
Interest expense
32,000
39,000
41,000
51,000
48,000
Income before tax
378,000
491,000
293,000
-738,000
210,000
Income tax expense
17,000
4,000
8,000
101,000
52,000
Income from continuing operations
361,000
487,000
285,000
-839,000
158,000
Net income
361,000
486,000
282,000
-843,000
155,000
Net income available to common shareholders
361,000
486,000
282,000
-843,000
155,000
Basic EPS
-
2.01
1.17
-3.51
0.67
Diluted EPS
-
2.00
1.17
-3.51
0.66
Basic average shares
-
242,000
241,000
240,000
233,000
Diluted average shares
-
243,000
242,000
241,000
234,000
EBITDA
-
629,000
455,000
554,000
404,000